New guidelines released for practitioners treating anaphylaxis and atopic dermatitis

Evidence-based recommendations for diagnosis and management of allergic conditions

2023-12-18

(Press-News.org) ARLINGTON HEIGHTS, Ill. – (December 18, 2023) — Two new practice parameters from the Joint Task Force for Practice Parameters (JTFPP) offer evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis (AD) in pediatric and adult patients. The Joint Task Force is a partnership between the American College of Allergy, Asthma and Immunology (ACAAI) and the American Academy of Allergy, Asthma and Immunology.

“Both anaphylaxis and atopic dermatitis are allergic conditions that affect millions of people – in the United States and around the world,” says allergist Jay Lieberman, MD, co-chair of the JTFPP Task Force. “We regularly update our practice parameters to make sure allergists and other healthcare practitioners are aware of best practices when diagnosing and managing these disorders. When physicians and their staffs are aware of updated guidance, it means patients are getting the best, most appropriate care.”

Anaphylaxis

“The 2023 JTFPP anaphylaxis practice parameter provides evidence-based recommendations to support optimal contextual care across contemporary practice settings,” says allergist David B.K. Golden, MDCM, lead author of the practice parameter. “With important new guidance related to diagnostic evaluation, anaphylaxis in infants and in community settings, epinephrine treatment, mast cell conditions, beta-blockers and ACE inhibitors, and peri-operative anaphylaxis, these guidelines translate recent advances in the understanding of severe allergic reactions to help all healthcare professionals provide individualized care to each patient at the right time, in the right place, every time.”

The practice parameter on anaphylaxis focuses on areas where new evidence has emerged, and recommendations have evolved.

Key anaphylaxis guideline highlights include:

Updates on recommendations regarding if a patient must go to the emergency room if they use epinephrine for anaphylaxis. Calling emergency services (EMS) after use of an epinephrine auto injector (EAI) may not be required if the patient experiences prompt, complete, and durable response to treatment and has access to additional EAIs. Situations that would warrant EMS activation include severe anaphylaxis, symptoms that do not resolve promptly, completely or nearly completely, or symptoms that return or worsen. Recommendations on how, where and by whom epinephrine auto injectors should be stored. Updates on the diagnosis of anaphylaxis. Revised criteria by the World Allergy Organization (WAO), Brighton, and Delphi Consensus groups aim to create more universally accepted definitions and criteria for anaphylactic reactions. Updates on how to recognize and treat anaphylaxis in infants. Diagnosing anaphylaxis in infants and toddlers can be challenging, and there are no age-specific anaphylaxis diagnostic criteria. Therefore, the current National Institute of Allergy and Infectious Diseases/Food Allergy & Anaphylaxis Network or World Allergy Organization anaphylaxis criteria should be used to establish the diagnosis of anaphylaxis in infants/toddlers. Updates on how to evaluate and treat anaphylaxis in relation to a surgery. Updates on nuances regarding the use of beta-blockers and ACE inhibitors in patients at risk for anaphylaxis. Atopic Dermatitis

“The 2023 JTFPP atopic dermatitis guideline represents an advancement in trustworthy allergy guidelines,” says allergist Derek Chu, M.D., Ph.D. “It is distinguished from other guidelines through systematic reviews of the evidence with multidisciplinary panelist engagement, adherence to GRADE – a rigorous guideline development process, as well as the involvement of the patient and caregiver voice from start to finish. Clear translation of evidence to clinically actionable and contextual recommendations, and novel approaches to facilitate knowledge translation were paramount. The guidelines emphasize, in addition to standards of trustworthiness, the third principle of evidence-based medicine: that evidence alone is never enough; that patient values and preferences are crucial to arriving at optimal recommendations. The new recommendations also reflect the evolution of diversity, equity and inclusion in approaching diagnosis and management of this condition.”

Key atopic dermatitis guideline highlights include:

Recommends the use of topical corticosteroids or topical calcineurin inhibitors in patients with uncontrolled AD, despite moisturizers. Highlights the safety of the topical calcineurin inhibitors with typical usage once or twice daily. Recommends proactive therapy with topical corticosteroids or topical calcineurin inhibitors for patients with a relapsing course. Consideration for once daily dosing of topical medications. Recommends dupilumab for patients 6 months of age or older with moderate-severe AD refractory, intolerant, or unable to use mid-potency topical treatment, or tralokinumab for similar patients ages 12 years and older. Suggests against elimination diets for AD. Suggests the usage of crisaborole 2% ointment for mild to moderate atopic dermatitis. Suggests against the use of topical antibiotics for AD alone with no infection. Suggests bleach baths for AD patients with moderate to severe disease as an additive therapy; suggests against use for mild AD. Suggests consideration of allergen immunotherapy for moderate to severe AD. Suggests use of oral JAK inhibitors after careful consideration of risks and benefits in adults and adolescents with moderate-severe AD refractory, intolerant, or unable to use mid to high potency topical treatment and biologics. Suggests against immunosuppressant medications such as baricitinib (a JAK inhibitor), azathioprine, methotrexate and, mycophenylate mofetil Suggests consideration of cyclosporin in adults and adolescents with moderate-severe AD refractory, intolerant, or unable to use mid to high potency topical treatment and biologics. Suggests against the use of systemic corticosteroids for AD. The practice parameters are published in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma & Immunology.

Review Anaphylaxis: A 2023 practice parameter update for complete recommendations.

Review Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations.

Related documents

Editorial: Anaphylaxis: A 2023 practice parameter update - Major changes in management of anaphylaxis

The Allergy Immunology Joint Task Force on Practice Parameters (JTFPP), a partnership between the American College of Allergy, Asthma, and Immunology (ACAAI) and the American Academy of Allergy, Asthma, and Immunology (AAAAI), has been informing evidence-based practice since 1989. The JTFPP works to develop both traditional practice parameters and GRADE (Grading of Recommendations Assessment, Development and Evaluation) guidelines which clearly describe evidence certainty and strength of recommendations, informed by clinical experts and patient partners. The 2023 Atopic Dermatitis and Anaphylaxis clinical guidelines released this month will advance equity and access while facilitating cost-effective, evidence-informed care that helps patients and healthcare professionals balance benefits and harms to achieve optimal health outcomes. In addition to these guidelines, the JTFPP is actively developing clinical guidelines on inborn errors of immunity, allergen immunotherapy, severe asthma, chronic urticaria, vaccine allergy, and food allergy, with recent guidelines available on drug allergy, chronic sinusitis, allergy diagnostics, eosinophilic esophagitis, allergic rhinitis, and stinging insect allergy available at www.allergyparameters.org .

About ACAAI

The American College of Allergy, Asthma & Immunology (ACAAI) is a professional medical organization of more than 6,000 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. Founded in 1942, the College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy, and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit AllergyandAsthmaRelief.org. Join us on Facebook, Pinterest, Instagram and X/Twitter. For more information, Hollis Heavenrich-Jones, hollisheavenrich-jones@acaai.org

About AAAAI

The American Academy of Allergy, Asthma & Immunology (AAAAI) is a medical organization of more than 7,100 allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI represents members in the United States, Canada and 72 other countries and is the go-to resource for patients living with allergies, asthma and immune deficiency disorders. Visit us at AAAAI.org. Join the conversation on Facebook, Instagram and Twitter/X. For more information: Lori Holly, lholly@aaaai.org

END

ELSE PRESS RELEASES FROM THIS DATE:

Spike in dermatology visits for skin problems seen during summer of wildfires

2023-12-18

New research suggests that air pollution may contribute to the development or worsening of skin conditions. The work, which is published in Dermatology and Therapy and led by scientists at Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham healthcare system, points to the need to improve air quality to lower the burden of skin disease, especially for vulnerable communities. “We were inspired to investigate the relationship between air pollution and skin inflammation after listening to patients who kept telling us that their skin conditions like eczema were particularly bad, and in some cases ‘worse than ever before,’ this summer,” ...

Melatonin and carcinogenesis in mice: The 50th anniversary of relationships

2023-12-18

“[...] murine models proved to be valuable and, in some cases, indispensable for advancing melatonin applications in oncology [...].” BUFFALO, NY- December 18, 2023 – A new research perspective was published in Oncotarget's Volume 14 on December 12, 2023, entitled, “Melatonin and carcinogenesis in mice: the 50th anniversary of relationships.” Fifty years ago, in 1973, Vladimir N. Anisimov and coauthors demonstrated for the first time an inhibitory effect of the pineal ...

Yale study finds “Forever chemicals” promote cancer migration

2023-12-18

New Haven, Conn. — In a new study by researchers at the Yale School of Public Health, two “forever chemicals” spurred cancer cells in the lab to migrate to new positions, an indication that the chemicals could contribute to cancer metastasis in living organisms. The study addressed the group of industrial chemicals called per- and polyfluoroalkyl substances (PFAS). The substances are known as “forever chemicals” because they don’t break down in the environment and can build up in the human body. They have the ability to shed water and resist penetration by oils. They are ...

New survey: 79% of survey respondents overlook their health needs during the holidays; find the holidays more stressful than tax season

2023-12-18

Survey Highlights: A majority of Americans (51%) say it takes them weeks to feel less stressed after the holidays, with more than a quarter of moms reporting it takes them a month or more to recover. 71% of respondents say that their biggest regret after the holidays is that they did not take the time to relax and enjoy the season. Overall, respondents (63%) claimed that the holiday season is more stressful than tax season. Eating healthy (69%), exercising regularly (64%), and getting enough sleep (56%) are the top three things that respondents have trouble prioritizing during the holiday season. 79% of people surveyed agree that, during the holidays, they are so focused on creating special ...

Public opinion polls may not be as straightforward as you think

2023-12-18

Public opinion polls are often considered "the will of the people" but a new study on the role of polls in South Korea shows that they may not always be that transparent. "Using polls to gauge what people think about politics is not as simple as it sounds, as there are multiple mediating factors between what people think and how their views may be represented in the media," says co-author Sunmin Kim, an assistant professor of sociology at Dartmouth. "Our research shows more broadly, how in a democracy, measuring what people think or want can be a highly haphazard and unpredictable process based on the ways public opinion poll ...

Study assesses GPT-4’s potential to perpetuate racial, gender biases in clinical decision making

2023-12-18

A team of Brigham researchers analyzed GPT-4’s performance in four clinical decision support scenarios: generating clinical vignettes, diagnostic reasoning, clinical plan generation and subjective patient assessments. When prompted to generate clinical vignettes for medical education, GPT-4 failed to model the demographic diversity of medical conditions, exaggerating known demographic prevalence differences in 89% of diseases. When evaluating patient perception, GPT-4 produced significantly different responses by gender or race/ethnicity for 23% of cases. Large language models (LLMs) like ChatGPT and GPT-4 have the potential to assist in ...

Apes remember friends they haven’t seen for decades

2023-12-18

Apes recognize photos of groupmates they haven’t seen for more than 25 years and respond even more enthusiastically to pictures of their friends, a new study finds. The work, which demonstrates the longest-lasting social memory ever documented outside of humans, and underscores how human culture evolved from the common ancestors we share with apes, our closest relatives, was published today in the journal Proceedings of the National Academy of Sciences. “Chimpanzees and bonobos recognize individuals even though they haven’t seen them for ...

Scientists might be using a flawed strategy to predict how species will fare under climate change

2023-12-18

EMBARGO LIFTS DEC. 18, 2023, AT 3:00 PM U.S. EASTERN TIME As the world heats up, and the climate shifts, life will migrate, adapt or go extinct. For decades, scientists have deployed a specific method to predict how a species will fare during this time of great change. But according to new research, that method might be producing results that are misleading or wrong. University of Arizona researchers and their team members at the U.S. Forest Service and Brown University found that the method – commonly referred to as space-for-time substitution – failed to accurately predict how a widespread tree of the Western U.S. called the ...

Mesopotamian bricks unveil the strength of Earth’s ancient magnetic field

2023-12-18

Ancient bricks inscribed with the names of Mesopotamian kings have yielded important insights into a mysterious anomaly in Earth’s magnetic field 3,000 years ago, according to a new study involving UCL researchers. The research, published in the Proceedings of the National Academy of Sciences (PNAS), describes how changes in the Earth’s magnetic field imprinted on iron oxide grains within ancient clay bricks, and how scientists were able to reconstruct these changes from the names of the kings inscribed on the bricks. The team hopes that using this “archaeomagnetism,” which looks for signatures ...

Move over dolphins. Chimps and bonobos can recognize long-lost friends and family — for decades

2023-12-18

Researchers led by a University of California, Berkeley, comparative psychologist have found that great apes and chimpanzees, our closest living relatives, can recognize groupmates they haven't seen in over two decades — evidence of what’s believed to be the longest-lasting nonhuman memory ever recorded. The findings also bolster the theory that long-term memory in humans, chimpanzees and bonobos likely comes from our shared common ancestor that lived between 6 million and 9 million years ago. The team used infrared eye-tracking cameras to record where bonobos and chimps gazed when they were shown side-by-side images of other bonobos ...

New guidelines released for practitioners treating anaphylaxis and atopic dermatitis

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: